Seed Co., Ltd. (7743) AI Stock Analysis

• Market Cap: ¥15.71B
• Dividend Yield: 2.88%
• Average Volume (3M): 68.06K
• Price to Earnings (P/E): 14.1
• Beta (1Y): 0.61
• Revenue Growth: 2.38%
• EPS Growth: -48.68%
• Country: JP
• Employees: 962
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 12.60
• Shares Outstanding: 30,265,923
• 10 Day Avg. Volume: 102,970
• 30 Day Avg. Volume: 68,056
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥569.00
• Price Target Upside: 9.63% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 67 Neutral
• Price Target: ¥569.00 ▲(9.63% Upside)

The stock score is primarily influenced by solid financial performance and reasonable valuation. The technical analysis indicates strong momentum but warns of overbought conditions. The absence of earnings call and corporate events data limits the analysis to these factors.

Seed Co., Ltd. Business Overview & Revenue Model

Company Description

SEED Co.,Ltd. manufactures and supplies contact lenses, care products, spectacle frames, and other eye care products in Japan and internationally. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; SEED MonthlyFine UV and monthly color lens UV replacement contact lenses; rigid gas permeable contact lenses; and medical contact lenses. In addition, the company offers glass frames under the Vivid Moon, ViVi fleurs, and Plusmix brand names; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products for better vision. SEED Co., Ltd. was founded in 1957 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Seed Co., Ltd. generates revenue primarily through the sale of its optical and medical products. The company's key revenue streams include the production and distribution of contact lenses and related lens care products, which are sold directly to consumers and through partnerships with healthcare providers and retailers. The company also collaborates with various opticians and eye care professionals to expand its market reach. Significant factors contributing to its earnings include continuous innovation in product development, strategic marketing efforts, and maintaining strong relationships with distribution partners.

Seed Co., Ltd. Financial Statement Overview

Summary

Seed Co., Ltd. shows growth in revenue and efficient operational management. However, declining net income and negative free cash flow pose concerns. The company's balance sheet remains stable, though high debt levels may require monitoring. Overall, the financial health is sound, but attention to cash flow management and profitability is needed.

Income Statement

The company has shown consistent revenue growth over the past years, with a revenue increase of 2.58% in the last fiscal year. The gross profit margin remains strong but has slightly decreased over time. The net profit margin showed a significant decline, primarily due to a substantial drop in net income. EBIT and EBITDA margins are stable, suggesting efficient operations despite the net income decline.

Balance Sheet

The balance sheet reveals a stable equity position with a debt-to-equity ratio that has remained relatively constant. The return on equity has been affected by the reduced net income, impacting overall profitability. The equity ratio remains healthy, indicating a solid foundation, but the high total debt level poses a risk.

Cash Flow

Operating cash flow has decreased, reflecting the decline in net income. Free cash flow turned negative in the last fiscal year, highlighting cash management challenges. The operating cash flow to net income ratio suggests cash flow generation is still fair, but free cash flow to net income indicates potential liquidity issues.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	33.23B	32.40B	30.59B	28.84B	28.62B
Gross Profit	14.63B	14.18B	11.62B	12.01B	12.41B
EBITDA	5.05B	4.88B	2.83B	4.45B	4.55B
Net Income	1.09B	1.96B	-316.09M	1.15B	1.13B
Balance Sheet
Total Assets	51.76B	49.57B	40.01B	41.79B	41.26B
Cash, Cash Equivalents and Short-Term Investments	7.12B	9.89B	4.94B	3.88B	3.96B
Total Debt	26.26B	24.30B	20.97B	22.09B	22.93B
Total Liabilities	33.38B	31.92B	27.87B	29.25B	29.61B
Stockholders Equity	18.06B	17.36B	11.86B	12.26B	11.49B
Cash Flow
Free Cash Flow	-1.70B	2.19B	2.79B	2.15B	1.52B
Operating Cash Flow	2.98B	6.02B	3.35B	3.27B	3.69B
Investing Cash Flow	-4.57B	-3.76B	-440.73M	-881.61M	-1.66B
Financing Cash Flow	-1.13B	2.64B	-1.82B	-2.42B	-1.73B

Seed Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 519.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7743, the sentiment is Positive. The current price of 519 is above the 20-day moving average (MA) of 483.40, above the 50-day MA of 466.86, and above the 200-day MA of 475.40, indicating a bullish trend. The MACD of 12.43 indicates Negative momentum. The RSI at 72.22 is Negative, neither overbought nor oversold. The STOCH value of 78.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7743.

Seed Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7743	67 Neutral	¥15.71B	14.09		2.88%	2.38%	-48.68%
Sector *	65 Neutral	¥341.94B	11.51	-0.17%	2.40%	9.60%	-10.22%
JNDOF	―	$1.30B	20.35	29.03%	2.60%	―	―
5FR	―	€513.15M	16.60	6.01%	―	―	―
5889	77 Outperform	¥53.56B	13.22		2.93%	17.45%	43.39%
7980	76 Outperform	¥5.72B	8.60		1.86%	5.45%	0.23%
7782	72 Outperform	¥3.82B	10.40		1.97%	16.73%	66.79%

Seed Co., Ltd. Corporate Events

SEED Co., Ltd. Expands Production Capacity with New Asset Acquisition

SEED Co., Ltd. announced its decision to acquire new fixed assets to enhance production capacity as part of its medium-term management plan. The expansion at the Kounosu Laboratory will increase production capacity by over 150% and support the introduction of next-generation silicone hydrogel lenses, positioning the company to better capture market growth.

Seed Co., Ltd. Reports Strong Growth in Q1 2025

Seed Co., Ltd. reported a 3.3% increase in net sales for the three months ending June 30, 2025, with significant growth in operating profit by 53.7% compared to the previous year. The company has expanded its consolidation scope by adding five new companies, indicating a strategic move to strengthen its market position. Despite a slight decrease in net assets and comprehensive income, the company maintains a positive outlook with an 11.3% projected increase in net sales for the fiscal year ending March 31, 2026.

Seed Co., Ltd. Addresses Prime Market Compliance Challenges

Seed Co., Ltd. announced that it is currently not in compliance with the Tokyo Stock Exchange Prime Market’s listing maintenance standards due to its tradable share market capitalization. The company has entered an improvement period until March 31, 2026, to meet these standards, failing which it may be delisted. As part of its medium-term management plan, Seed Co., Ltd. is working to boost its global contact lens market presence by increasing production capacity, meeting market needs, and promoting sustainable development goals.

SEED Co., Ltd. Updates Mid-Term Management Plan

SEED Co., Ltd. has updated its Mid-Term Management Plan, originally announced in January 2024, to reflect changes in the business environment and recent sales progress. The company remains committed to its original goals and has reviewed its priority issues to align with its purpose and management philosophy.

SEED Co., Ltd. Announces New Director Appointment

SEED Co., Ltd. has announced a planned change in its board of directors, with the appointment of Fujita Reiji as a new director. This strategic move is expected to be finalized at the upcoming Ordinary General Meeting of Shareholders, potentially impacting the company’s governance and strategic direction.

SEED Co., Ltd. Announces Dividend Payment for Fiscal Year 2025

SEED Co., Ltd. announced a decision to pay a dividend of 15 yen per share from retained earnings, with a record date of March 31, 2025. This move aligns with the company’s policy to provide stable returns to shareholders while maintaining a strong management foundation, and it will be proposed at the upcoming Ordinary General Meeting of Shareholders.

Seed Co., Ltd. Reports Decline in Profits Despite Sales Growth

Seed Co., Ltd. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing a slight increase in net sales by 2.6% to 33,231 million yen. However, the company experienced a significant decline in profits, with operating profit down by 23.8% and ordinary profit decreasing by 35.3%. The profit attributable to owners of the parent dropped by 44.4% compared to the previous year. Despite these challenges, the company forecasts a positive outlook for the fiscal year ending March 31, 2026, with expected growth in net sales and profits, indicating strategic adjustments to improve financial performance.